Issues related to the federal government drug payment policies in the reformed health care environment
Subtitle: final report
By: Principal Investigator: David J. Gross, Ph.D.
Contributors: United States. Health Care Financing Administration; KPMG Peat Marwick. Policy Economics Group
Publisher: KPMG Peat Marwick, Policy Economics Group
Published: 1995
Place of publication: Washington, D.C
Language: eng
Subjects: Drugs; Costs; Government policy; Pharmaceutical services insurance; Medicaid; Economic aspects; Health care reform
Notes: "HCFA contract number: 500-93-0031; Contract amount: $128,288; Project Director: Kathryn Langwell."

"September 14, 1995."

"Prepared for: Health Care Financing Administration, Office of Research and Demonstration ... Jay Bae, Ph.D., Project Officer; Submitted by: KPMG Peat Marwick LLP, Policy Economics Group."

"This is a competitively awarded contract, awarded in response to RFP no. HCFA-94-036/PK.

Includes bibliographical references.

CMS copy in folder: Issues related to the federal government drug payment policies.